Breaking News

Tweet TWEET

Novo Nordisk Wins Modern Insulin Market Share, Berlingske Says

Novo Nordisk A/S has increased its share of the global market for modern insulin to 40.5 percent in 2009 from 38 percent in 2008, Copenhagen-based newspaper Berlingske Tidende reported today citing its own research.

Click here for web link

To contact the editor responsible for this story: Gelu Sulugiuc at gsulugiuc@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.